This study conducted an independent national evaluation of 18 networks composed of multiple HRSA- supported community health centers that collaborated with a school of pharmacy to introduce or expand comprehensive pharmacy services at their health center sites. The study used both quantitative and qualitative methods. The quantitative analyses were conducted to examine: (1) the extent to which projects reached and retained their target population; (2) the health outcomes of patients in these target populations; (3) the operational and economic outcomes of each health center that participated in these projects. Qualitative analyses were based on discussions with stakeholders from each network. Overall, findings indicate use of a clinical pharmacist to provide disease management services appears to add another potentially effective tool to the toolbox that health centers (and, potentially, other practice settings) can use to improve the clinical outcomes of people with diabetes. In order for clinical pharmacy services to become a widely used tool for improving care, the financing of services, physician support and relationships between health centers and schools of pharmacy will all need to be favorably resolved.
Future research may include an examination of the extent to which these services are cost-effective and effective relative to other competing “best practice” approaches.
PIC ID: 7959; Agency Sponsor: HRSA-BPHC, Bureau of Primary Health Care; Federal Contact: McGee, Kathy, 301-594-0318; Performer: Mathematica Policy Research, Inc., Plainsboro, NJ